Rashtriya Newsflash

Press Release

Hu Jiaqi’s Core Thought on Humanity’s Issues

In an era when human civilization is mired in existential crises like runaway technological advancement, ecological collapse and geopolitical conflicts, Hu Jiaqi, after more than four decades of dedicated intellectual

Read Full Article

Myasthenia Gravis Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Alpine Immune Science, Toleranzia, Cabaletta Bio, Rallybio, Alexion

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myasthenia Gravis pipeline constitutes 20+ key companies continuously working towards developing 22+ Myasthenia Gravis treatment therapies, analysis of Clinical Trials,

Read Full Article

Looking Back at the Journey, Climbing Verdant Peaks – The Ten-Year Development Journey of Slkor Semiconductor

SLKOR, based in Shenzhen, China, is a fast-growing high-tech enterprise in the power semiconductor sector. With R&D centers in Beijing and Suzhou, its team, primarily from Tsinghua University, specializes in

Read Full Article

Dry Eye Disease Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Laboratorios Sophia, Iolyx Therapeutics, Oculis Pharma, HanAll BioPharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Dry Eye Disease pipeline constitutes 50+ key companies continuously working towards developing 60+ Dry Eye Disease treatment therapies, analysis of

Read Full Article

Charcot Marie Tooth Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pharnext SA, MedDay Pharma, HELIXMITH, ENCell, Chong Kun Dang Pharm

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Charcot Marie Tooth Disease pipeline constitutes 10+ key companies continuously

Read Full Article

Giant-Cell Arteritis Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | AbbVie, Novartis, CSL, Kiniksa Pharma, Eli Lilly, Roche, Johnson & Johnson, MorphoSys AG

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Giant-Cell Arteritis pipeline constitutes 6+ key companies continuously working towards

Read Full Article

Verrica’s VP-102 Advances Dermatology Care: First Patient Dosed in Global Phase 3 Common Warts Program

Verrica Pharmaceuticals doses first patient in global Phase 3 VP-102 trial for common warts, expanding beyond molluscum contagiosum treatment.  

Read Full Article

Patty Shukla to Collaborate with Leading Australian Children’s YouTube Artists and Announce Live Appearances in Uruguay

Internationally recognized early childhood music educator and children’s artist Patty Shukla has announced upcoming international collaborations and live appearances scheduled

Read Full Article

Myotonic Dystrophy Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Myotonic Dystrophy Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Myotonic Dystrophy

Read Full Article

Fibromyalgia Clinical Trial Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Fibromyalgia Pipeline Insight 2026” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Fibromyalgia pipeline landscape.

Read Full Article